ClinicalTrials.Veeva

Menu

Effectiveness of Behavioral Activation Treatment for Schizophrenia

I

Inha University Hospital

Status

Enrolling

Conditions

Negative Symptoms in Schizophrenia
Remote Medical Service
Behavioral Activation
Schizophrenia, Latent

Treatments

Behavioral: behavioral activation

Study type

Interventional

Funder types

Other

Identifiers

NCT05764148
2021-01-026

Details and patient eligibility

About

The purpose of this study is to implement a behavior activation remote program for negative symptoms of schizophrenia and to verify whether the behavior activation remote program for negative symptoms of schizophrenia has effects on negative symptoms, cognitive function, and social function of schizophrenia.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have received a primary diagnosis of schizophrenia
  • Patients who are at least 18 years old and under 65 years old
  • Patients who show a score of 3 or higher on at least two negative symptom items in the Positive and Negative Syndrome Scale (PANSS)
  • The subject selection period is until December 31, 2021, from the IRB approval date.

Exclusion criteria

  • Patients with a history of organic brain syndrome, epilepsy, or traumatic brain injury
  • Patients with comorbidities such as intellectual disability, current alcohol or other substance dependence
  • Patients who show a score of 5 or higher on at least two positive symptom items in the Positive and Negative Syndrome Scale (PANSS)
  • Patients who have received a diagnosis of major depressive disorder according to the DSM-V criteria by a specialist in psychiatry
  • Patients who have received psychological services including components of behavioral activation therapy
  • Patients who are at risk of self-harm or harm to others.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups, including a placebo group

Behavioral activation
Experimental group
Description:
Behavioral activation
Treatment:
Behavioral: behavioral activation
Traatment as usual
Placebo Comparator group
Treatment:
Behavioral: behavioral activation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems